Use of continuous glucose monitoring in patients with type 1 diabetes

Current Diabetes Reviews

Volumn 4, Issue 3, 2008, Pages 207-217

  Ellis, Samuel L ^a   Naik, Ramachandra G ^a   Gemperline, Kate ^a   Garg, Satish K ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

Continuous glucose monitoring; Glucose variability; HbA1c; Hypoglycemia; Type 1 diabetes mellitus

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN;

BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; DEVICE; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; OUTCOMES RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; REVIEW; SAFETY; SELF MONITORING; SENSOR;

BIOSENSING TECHNIQUES; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; EQUIPMENT DESIGN; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; MONITORING, AMBULATORY; PREVALENCE; SELF CARE; UNITED STATES;

EID: 54749142477     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339908785294370     Document Type: Review

References (47)

1. Diabetes Epidemiology Research International Group. Secular trends in incidence of childhood IDDM in 10 countries. Diabetes Epidemiology Research International Group. Diabetes 1990; 39: 858-864.
2. Onkamo P, Vaananen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of Type I diabetes - the analysis of the data on published incidence trends. Diabetologia 1999; 42: 1395-1403.
3. Vehik K, Hamman RF, Lezotte D, et al. Increasing incidence of type 1 diabetes mellitus in 0-17 year old colorado youth. Diabetes 2006; 55: (Suppl 1): A56.
4. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004; 291: 335-342.
5. Group TDCaCTR. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
6. The Diabetes Control and Complications Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995; 44; 968-983.
7. Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006; 295: 1681-1687.
8. GlucoWatch Biographer: http://www.glucowatch.com. In.
9. Bailey TS, Zisser HC, Garg SK. Reduction in hemoglobin A1c with real-time continuous glucose monitoring: Results from a 12-week study. Diabetes Technol Ther 2007; 9: 203-210.
10. Deiss D, Bolinder J, Riveline JP, et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 2006; 29: 2730-2732.
11. Garg S, Jovanovic L. Relationship of fasting and hourly blood glucose levels to HbA1c values: Safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor; Diabetes Care 2006; 29: 2644-2649.
12. Garg S, Zisser H, Schwarz S, et al. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: A randomized controlled trial. Diabetes Care 2006; 29: 44-50.
13. Ellis S, Voemle M, Garg S, et al. Improved glycemic control with real-time continuous glucose sensors in patients with type 1 diabetes. In: The 67th Annual Meeting:of the American Diabetes Association Chicago, IL: Diabetes 2007; p. A119
14. Ellis SL, Bookout T, Izuora KE, Garg SK. Use of continuous glucose monitoring to improve diabetes mellitus management. Endocrinol Metab Clin North Am 2007; 36 (Supp 2): 44-68.
15. Kilpatrick ES, Rigby AS, Atkin SL. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 2006; 29: 1486-1490.
16. DexCom STS Glucose Monitoring System: http://www.dexcom.com. In.
17. Paradigm REAL-Time http://www.minimed.com/products/insulinpumps/ index.html. In.
18. Guardian REAL-Time: www.minimed.com/products/guardian. In.
19. The Diabetes Research in Children Network (DirecNet) Study Group. Psychological aspects of continuous glucose monitoring in pediatric type 1 diabetes. Pediatr Diabetes 2006; 7: 32-38.
20. FreeStyle Navigator®: http://www.abbottdiabetescare.com/adc_dotcom/ url/content/en_US/10.10:10/general_content/General_Content_0000163.htm. In.
21. Brauker J, Kamath A, Li Y, et al. Time lag of a seven-day transcutaneous glucose sensor compared to YSI blood glucose values. In: 67th Scientific Sessions and Annual Meeting of the American Diabetes Association. Chicago IL: Diabetes 2007; Abstract P-448.
22. Clarke WL, Cox D, Gonder-Frederick LA, et al. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987; 10: 622-628.
23. Kovotchev BP, Gonder-Frederick LA, Cox DJ, Clarke WL. Evaluating the accuracy of continuous glucose-monitoring sensors: Continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator data. Diabetes Care 2004; 27: 1922-1928.
24. Mazze R, Strock E, Wesley D, et al. Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and Ambulatory Glucose Profile (AGP) analysis. Diabetes Technol Ther 2008; 10: (in press).
25. Chico A, Vidal-Rios P, Subira M, Novials A. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic centro. Diabetes Care 2003; 26: 1153-1157.
26. Schiaffini R, Ciampalini P, Fierabracci A, et al. The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk. Diabetes Metab Res Rev 2002; 18: 324-329.
27. Garg SK, Kelly WC, Voelmle MK, et al. Improved glycemic control with real-life use of continuous glucose sensors in adult subjects with type 1 diabetes. Diabetes Care 2007; 30: 3023-3025.
28. Maia FFR, Araújo LR. Acurácia, utilidade e complicações da monitorização subcutânea contínua da glicose (CGMS) em pacientes pediátricos com diabetes tipo 1. J Pediatr 2005; 81: 293-297.
29. Maia FFR, Araújo LR. Eficácia da monitorização subcutânea contínua da glicemia (CGMS) na detecção da hipoglicemia assintomática em crianças e adolescents com diabetes tipo 1. Bras Endocrinol Metab 2005; 49: 569-574.
30. The Diabetes Research in Children Network (DirecNet) Study Group. Continuous glucose monitoring in children with type 1 diabetes. J Pediatr 2007; 151: 388-393.
31. Chase HP, Roberts MD, Wightman C, et al. Use of the GlucoWatch biographer in children with type 1 diabetes. Pediatrics 2003; 111: 790-794.
32. Tanenberg R, Bode B, Lane W, et al. Use of the Continuous Glucose Monitoring System to guide therapy in patients with Insulin-treated diabetes: A randomized controlled trial. Mayo Clin Proc 2004; 79: 1521-1526.
33. Weintrop N, Schechter A, Benzaquen H, et al. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion. Arch Pediatr Adolesc Med 2004; 158: 677-684.
34. Hirsch IB, Bode BW, Abelseth J, et al. Sensor Augmented Pump Therapy: Results of the First Treat-To-Target Study. In: 67th Scientific Sessions of the American Diabetes Association. Chicago IL: Diabetes; 2007. Abstract OR-0090.
35. Bohannon N, Blevins T, Bloomgarden D, et al. Patient use patterns in continuous glucose monitoring. In: 68th Scientific Sessions and Annual Meeting of the American Diabetes Association. San Francisco CA: Diabetes; 2008.
36. Mortensen HB, Hougaard P, The Hvidore Study Group on Childhood Diabetes. Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries. Diabetes Care 1997; 20: 714-720.
37. Mortensen HB, Robertson KJ, Aanstoot HJ, et al. Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence In 18 countries. Diabet Med 1998; 15: 752-759.
38. Rosilio M, Cotton JB, Wieliczko MC, et al. Factors associated with glycemic control: a cross-sectional nationwide study in 2,579 French children with type 1 diabetes. Diabetes Care 1998; 21: 1146-1153.
39. Scottish Study Group for the Care of the Young Diabetic. Factors influencing glycemic control in young people with type 1 diabetes In Scotland: a population-based study (DIABAUD2). Diabetes Care 2001; 24: 239-244.
40. The Diabetes Control and Complications Trial Research Group. Effect of Intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: diabetes control and complications trial. J Pediatr 1994; 125: 177-188.
41. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the diabetes control and complications trial. Diabetes 1997; 46: 271-286.
42. McCarthy AM, Lindgren S, Mengeling MA, et al. Factors associated with academic achievement In children with type 1 diabetes. Diabetes Care 2003; 26: 112-117.
43. Chase HP, Kim LM, Owen SL, et al. Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics 2001; 107: 222-226.
44. The Diabetes Research In Children Network (DirecNet) Study Group. A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring In children with type 1 diabetes. Diabetes Care 2005; 28: 1101-1106.
45. The Diabetes Research In Children Network (DirecNet) Study Group. Youth and parent satisfaction with clinical use of the GlucoWatch G2 Biographer in the management of pediatric type 1 diabetes. Diabetes Care 2005; 28:1929-1935.
46. Garg SK, Schwartz S, Edelman SV. Improved glucose excursions using an implantable real-time continuous glucose sensors in adults with type 1 diabetes. Diabetes Care 2004; 27: 734-738.
47. Tamborlane W, Ruedy K, Wysocki T, et al. JDRF randomized clinical trial to assess the efficacy,of real-time continuous glucose monitoring in the management of type 1 diabetes: Research design and methods. Diabetes Technol Ther 2008; In press.